Back Pain News and Research

Latest Back Pain News and Research

Military personnel with back pain unlikely to return to duty after treatment

Military personnel evacuated out of Iraq and Afghanistan because of back pain are unlikely to return to the line of duty regardless of the treatment they receive, according to research led by a Johns Hopkins pain management specialist.

9 Nov 2009

Health education on ID and stability balls, an opportunity for healthier life

An Indiana University study involving adults with intellectual disabilities found that the adults increased their personal health knowledge after taking a semi-weekly class for four weeks.

9 Nov 2009

Facet Solutions announces Archus Orthopedics acquisition

Facet Solutions, Inc. announced today that it has acquired all of the assets of Archus Orthopedics. The acquisition creates an undisputed leadership position in product offerings, intellectual property and clinical experience in posterior motion preservation. "This is a win for patients suffering from lumbar spinal stenosis," stated Facet Solutions' President & CEO, Geoff Pardo. "This consolidation further strengthens Facet Solutions' position in lumbar spine motion preservation surgery, which is the fastest growing sector of the surgical spine marketplace."

6 Nov 2009

Yoga may be more effective for reducing chronic low back pain, say researchers

Researchers from Boston University School of Medicine (BUSM) and Boston Medical Center found that yoga may be more effective than standard treatment for reducing chronic low back pain in minority populations. This study appears in the November issue of Alternative Therapies in Health and Medicine.

5 Nov 2009

Spinal Modulation completes its $27.4 million Series C financing

Spinal Modulation, Inc. announced today the completion of its $27.4 million Series C financing. Johnson & Johnson Development Corporation (JJDC) joined existing major investors including DeNovo Ventures, ePlanet/DFJ, Kleiner Perkins Caufield & Byers, and MedVenture Associates in this financing. DFJ/InCube Ventures and Raffles Venture Partners are additional new investors.

4 Nov 2009

Gilead Sciences to present Viread Phase III clinical trial data

Gilead Sciences, Inc. today announced the presentation of three-year (144-week) open label data from two pivotal Phase III clinical trials, Studies 102 and 103, evaluating the safety and efficacy of once-daily Viread® (tenofovir disoproxil fumarate) among adult patients with chronic hepatitis B virus (HBV) infection.

2 Nov 2009

Dr. Chao Herbal Drink Line releases two all-natural, vegan beverages

The Dr. Chao Herbal Drink Line released two all-natural, vegan beverages to enhance sexual health and combat premenstrual symptoms. The new Adult and Lady drinks have no sugar, artificial sweeteners or preservatives, glutens, and caffeine, do not require costly prescriptions and have health benefits derived from the recipes of a 19th-century Chinese herbalist.

30 Oct 2009

Patient self-referral to physiotherapy proven to be safe, and results in better health outcomes

Today in Washington, DC, physiotherapists from around the world heard that direct patient access and self-referral to physiotherapy improves public health. Patient self-referral and direct access is proven to be safe, and results in better health outcomes, more timely care, higher patient satisfaction, and lower costs.

28 Oct 2009

Discovery of AVM can relieve pain due to chronic back pain and neurologic deficits

The discovery of a multi-level arteriovenous malformation (AVM) in the thoracic epidural space can now bring relief to potentially thousands of suffers of chronic thoracic pain and progressive myelopothy. Identified as thoracic epidural arteriovenous malformation (T.E.A.M.), this particular AMV primarily affects younger women ages 20 to 40.

27 Oct 2009

Lack of optimal pain care delivery system costs more than $100 billion each year

A new Pain Medicine Position Paper published by leaders of the American Academy of Pain Medicine (AAPM), reveals businesses lose $61 billion annually due to ineffective pain care and the lack of optimal pain care delivery.

27 Oct 2009

Quality of U.S. health care was virtually stagnant in 2008, says NCQA report

A report released today by the National Committee for Quality Assurance (NCQA) finds that the quality of U.S. health care was virtually stagnant in 2008, a disturbing slowdown after a decade of improvements. The across-the-board trend was seen in care provided to people with private insurance coverage as well as in Medicare and Medicaid.

23 Oct 2009

Musculoskeletal patients and their advocates to participate in more than 175 Congressional visits

The United States Bone and Joint Decade (USBJD) today announces that as part of its 2009 Advocacy Day nearly 80 musculoskeletal patients and patient advocates from across the nation are participating in more than 175 Congressional visits. Patients and their advocates -- physicians, family members and USBJD participating partners -- are raising awareness of the huge burden that musculoskeletal conditions plays on the U.S. These conditions are some of the most costly, common, and disabling conditions to date.

22 Oct 2009

Study results of PTH1-34 oral parathyroid hormone presented

Emisphere Technologies, Inc. today announced study results demonstrating that a single dose of the novel oral parathyroid hormone PTH1-34, which utilizes Emisphere’s proprietary Eligen® Drug Delivery Technology and absorption-enhancer carrier molecule 5-CNAC, achieved potentially therapeutically relevant exposure and safety profiles to those of the currently available injectable formulation in healthy postmenopausal women.

22 Oct 2009

Addition of chiropractic care increases value in US employer-sponsored health benefit plans

A report, prepared by a global leader for trusted human resources and related financial advice, products and services, finds that the addition of chiropractic care for the treatment of low back and neck pain will likely increase value-for-dollar in US employer-sponsored health benefit plans.

21 Oct 2009

Statewide Initiative to increase sudden cardiac arrest survival rates launched in Minnesota

Medtronic Foundation and Take Heart Minnesota™ today announced a comprehensive statewide initiative, the first in the nation, designed to increase sudden cardiac arrest (SCA) survival rates. SCA is a condition in which the heart abruptly stops without warning. More than 4,500 cases of SCA were reported in Minnesota in 2008, an average of 12.5 incidences per day.

21 Oct 2009

UCB reports on the outcome of Cimzia and MTX treatment for rheumatoid arthritis

UCB today announced data that showed rapid and sustained improvements in ACR20, physical function, pain and fatigue of rheumatoid arthritis (RA) as early as the first week, and inhibition of progression of structural joint damage (seen at week 24) following treatment with Cimzia (certolizumab pegol), together with methotrexate (MTX), was sustained up to 100 weeks.

19 Oct 2009

Boehringer Ingelheim Pharmaceuticals receives NDA approval from FDA for its Micardis Tablets 80 mg

Boehringer Ingelheim Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) approved the supplemental New Drug Application (sNDA) for its angiotensin II receptor blocker (ARB) Micardis® (telmisartan) Tablets 80 mg for reduction of the risk of myocardial infarction, stroke, or death from cardiovascular causes in patients 55 years of age or older at high risk of developing major cardiovascular events who are unable to take angiotensin-converting enzyme (ACE) inhibitors.(1) MICARDIS is the most studied ARB in this high-risk patient population and has been commercially available to treat hypertension (high blood pressure) since its approval in 1998.

19 Oct 2009

Initiative calls for more research and improved treatment methods on musculoskeletal pain

The Global Year Against Musculoskeletal Pain launches today, focusing attention on one of the largest and most significant areas of pain.

19 Oct 2009

Cobroxin OTC pain reliever is now available online

Nutra Pharma Corp., a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), has announced today that its over-the-counter pain reliever, Cobroxin, is available for sale online at Cobroxin.com.

15 Oct 2009

Foundation for Chiropractic Progress joins 92 national associations in support of World Spine Day

The Foundation for Chiropractic Progress (www.f4cp.com), a not-for-profit organization dedicated to increasing public awareness of the benefits of chiropractic, joins the 92 national associations that are currently members of the World Federation of Chiropractic in support of World Spine Day taking place on October 16, 2009.

15 Oct 2009

Back Pain News and Research

Latest Back Pain News and Research

Military personnel with back pain unlikely to return to duty after treatment

Health education on ID and stability balls, an opportunity for healthier life

Facet Solutions announces Archus Orthopedics acquisition

Yoga may be more effective for reducing chronic low back pain, say researchers

Spinal Modulation completes its $27.4 million Series C financing

Gilead Sciences to present Viread Phase III clinical trial data

Dr. Chao Herbal Drink Line releases two all-natural, vegan beverages

Patient self-referral to physiotherapy proven to be safe, and results in better health outcomes

Discovery of AVM can relieve pain due to chronic back pain and neurologic deficits

Lack of optimal pain care delivery system costs more than $100 billion each year

Quality of U.S. health care was virtually stagnant in 2008, says NCQA report

Musculoskeletal patients and their advocates to participate in more than 175 Congressional visits

Study results of PTH1-34 oral parathyroid hormone presented

Addition of chiropractic care increases value in US employer-sponsored health benefit plans

Statewide Initiative to increase sudden cardiac arrest survival rates launched in Minnesota

UCB reports on the outcome of Cimzia and MTX treatment for rheumatoid arthritis

Boehringer Ingelheim Pharmaceuticals receives NDA approval from FDA for its Micardis Tablets 80 mg

Initiative calls for more research and improved treatment methods on musculoskeletal pain

Cobroxin OTC pain reliever is now available online

Foundation for Chiropractic Progress joins 92 national associations in support of World Spine Day

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Back Pain News and Research

Latest Back Pain News and Research

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Newsletters you may be interested in